DNA analysis of in situ ductal carcinoma of the breast via flow cytometry
✍ Scribed by Gyda Lolk Ottesen; Ib Jarle Christensen; Jørgen K. Larsen; Jette Christiansen; Bodil Hansen; Johan A. Andersen
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 834 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr
Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents
Although chemopreventive anti-steroids such as the antiestrogens are thought to act through competitive inhibition of agonist binding to estrogen receptors, it has been postulated that the estrogen receptor changes its conformation when bound to a strong antiestrogen such as ICI-164,384. We hypothes